Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy; public health service statement

De Cock, Kevin M.; Holtgrave, David R.; Janssen, Robert S.; Smith, Dawn K.

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Management of possible sexual, injecting-drug-use, or other nonoccupational exposure to HIV, including considerations related to antiretroviral therapy; public health service statement

Published Date:

September 25, 1998

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 47, no. RR-17

[PDF-215.93 KB]

Details:

Personal Author:

De Cock, Kevin M. ; Holtgrave, David R. ; Janssen, Robert S. ; Smith, Dawn K. ;

Corporate Authors:

National Center for HIV, STD, and TB Prevention (U.S.), Division of HIV/AIDS Prevention--Surveillance and Epidemiology. ; Centers for Disease Control and Prevention (U.S.) ;

Description:

The most effective methods for preventing human immunodeficiency virus (HIV) infection are those that protect against exposure to HIV. Preventive behaviors include sexual abstinence, sex only with an uninfected partner, consistent and correct condom use, abstinence from injecting-drug use, and consistent use of sterile equipment by those unable to cease injecting-drug use. Some healthcare providers have proposed offering antiretroviral drugs to persons with unanticipated sexual or injecting-drug-use HIV exposure to prevent transmission. However, because no data exist regarding the efficacy of this therapy for persons with nonoccupational HIV exposure, it should be considered an unproven clinical intervention. Health-care providers and their patients may opt to consider using antiretroviral drugs after nonoccupational HIV exposures that carry a high risk for infection, but only after careful consideration of the potential risks and benefits and with a full awareness of the gaps in current knowledge. To address concerns related to providing antiretroviral agents to persons after nonoccupational HIV exposure, CDC convened a meeting in July 1997 of scientists, public health experts, clinicians, members of professional associations, representatives from industry, ethicists, and members of affected communities. This report reviews the topics raised at the meeting, provides background information on patient management options, and presents considerations for antiretroviral therapy.

Content Notes:

"The following CDC staff members prepared this report: Dawn K. Smith ... [et al.]"--P. ii. Includes bibliographical references (p. 12-14).

Subject:

[+]

Pubmed ID:

9763107

Document Type:

Journal Issue

Collection(s):

Stephen B. Thacker CDC Library collection

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Supplementary Table. Percent of children introduced to complementary foods before 4 months by state among children 1-5 years - United States, National Survey of Children's Health, 2016-2018

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

11/27/2020

Series:

MMWR. Morbidity and mortality supplementary materials

Description:

MMWR Supplementary Table for Volume 69 no. 47

Public Access
Available on:

November 25, 2020
COVID-19 Outbreak At an Overnight Summer School Retreat ― Wisconsin, July–August 2020

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

10/30/2020

Series:

MMWR. Morbidity and mortality supplementary materials

Description:

MMWR Supplementary Table for Volume 69 no.43

Public Access
Available on:

October 27, 2020
COVID-19 Outbreak Among a University’s Men’s and Women’s Soccer Teams —Chicago, Illinois, July–August 2020

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

10/27/2020

Series:

MMWR. Morbidity and mortality supplementary materials

Description:

MMWR Supplementary Table for Volume 69 no. 43

Public Access
Available on:

October 26, 2020
Supplemetary Table 3 for Vaccination Coverage by Age 24 Months Among Children Born in 2016 and 2017 – National Immunization Survey-Child, United States, 2017-2019

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

10/23/2020

Series:

MMWR. Morbidity and mortality supplementary materials

Description:

MMWR Supplementary Table for Volume 69 no. 42

File Type:

[PDF - 411.20 KB]
Supplemetary Table 2 for Vaccination Coverage by Age 24 Months Among Children Born in 2016 and 2017 – National Immunization Survey-Child, United States, 2017-2019

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

10/23/2020

Series:

MMWR. Morbidity and mortality supplementary materials

Description:

MMWR Supplementary Table for Volume 69 no. 42

File Type:

[PDF - 290.58 KB]